Market Research Blog – Page 9400 – New Product Development

Advancement in API Manufacturing and Growing Prevalence of Chronic Diseases to Steer Korea Cholesterol API Sales Past US$ 9.30 Mn in 2032

[345 Pages Report] The global cholesterol active pharmaceutical ingredient (API) market is projected to be valued at US$ 269.0 Mn by 2022, expanding at a CAGR of 4.7% between 2022 and 2032. By 2032, the global market for cholesterol API is expected to be worth US$ 426.9 Mn.

In Korea, the market for cholesterol APIs is anticipated to grow at a sluggish rate of CAGR of 3.9% over the forecast period, according to FMI. Sales in Korea cholesterol API market are projected to reach US$ 6.36 Mn by 2022. By the year 2032, it is expected that the market for cholesterol API in Korea would reach at a value of US$ 9.30 Mn. For the base year, a historical market worth of US$ 6.14 Mn has been registered.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15406

Government regulations that favor API development and changes in geopolitical conditions are driving market expansion. The expansion is due to advancements in manufacturing active pharmaceutical ingredients (APIs) and the increased incidence of chronic diseases, including cancer and cardiovascular disorders.

The governments of various regions have also developed policies and provided incentives to encourage the production of API. Pharmaceutical firms take advantage of API production outsourcing since it eliminates the requirement for costly manufacturing unit installation and labor force. Thus, outsourcing is encouraged by the demand for cost savings.

IOL Chemicals & Pharmaceuticals announced that the Korean Ministry of Food and Drug Safety had approved its active pharmaceutical ingredient (API) products, ibuprofen and fenofibrate. According to a regulatory filing by IOL Chemicals & Pharmaceuticals, the Korean Ministry of Food and Drug Safety certification re-establishes the company’s efforts to maintain the highest quality standards and increase its position in regulated markets.

Key Takeaways from the Cholesterol API Market

The market for cholesterol APIs in Korea is anticipated to grow at a CAGR of 3.9% over the forecast period.
Korea cholesterol API market is projected to reach a value of US$ 9.30 Mn by the end of 2032.
For the base year2021, Korea cholesterol API market recorded revenues of US$ 6.14 Mn.
In 2022, the market for cholesterol API in Korea is anticipated to hold a share of 11.2%.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15406

“Change in geopolitical environment, government policies that support API development, and improvement in the production of active pharmaceutical ingredients (APIs) will propel the demand. Further, rise in chronic diseases including cancer and cardiovascular diseases will create conducive environment for the key players.” – Says an FMI Analyst.

Competition Landscape in the Cholesterol API Market

Companies in the cholesterol API market are creating new designs and features in order to expand their market share. To improve the position in the global market, companies are focusing on a variety of strategies, such as M&A and the creation of new products.

Samsung Biologics, Daewoong Pharmaceutical, and Chong Kun Dang Pharmaceutical are some of the leading players in the Korea threat hunting market.

Recent Developments

In January 2022, Samsung Biologics entered into an agreement with Biogen to acquire Biogen’s stake in the Samsung Bioepis joint venture for US$ 2.3 billion. By fully utilizing Samsung Bioepis’ growth prospective, the deal is anticipated to increase Samsung Biologics’ overall earnings growth.
In August 2022, Daewoong Pharmaceutical is a South Korean pharmaceutical business that is publicly traded and develops, manufactures, and commercializes medications globally announced that DWP213388, a novel medication candidate being developed for autoimmune illnesses, has received approval from the U.S. Food and Drug Administration (FDA) to begin a Phase 1 clinical trial.

Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-15406

Cholesterol API Market Outlook by Category

By Source:

Animal Derived
Plant Derived
Synthetic

By Manufacturing Process:

GMP
Non – GMP

By End User:

RNA Vaccines
Monoclonal Antibodies
Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Cosmetic Dental Procedures are Expected to Grow the Market for Dental Adhesives in Japan.

According to the forecast, Japan will hold the largest market during the forecast period. Changing lifestyles, a growing geriatric population, and increasing occurrence of dental decay are expected to lead to market growth in the region. Increasing health awareness in Japan will provide better growth opportunities for dental adhesives in the market. Social media trends and high capital investments required for cosmetic dental treatments are expected to continue to contribute to the growth of the market in Japan for dental adhesives in the near future.

As clinics and hospitals have mushroomed in recent years, particularly in emerging markets, advanced technologies have been rapidly adopted in dentistry, and the clinic clientele has grown, the large share can be attributed to these factors. Further, dental adhesives are expected to become increasingly popular as the demand for cosmetic dentistry and restorative procedures increases.

𝑮𝒆𝒕 𝑳𝒂𝒕𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚 : https://www.futuremarketinsights.com/reports/sample/rep-gb-15784

One of the major factors driving the growth of the dental adhesive market is the rise in the prevalence of dental disorders around the world. The dental adhesive market will also experience profitable growth between 2022 and 2032 as adhesive systems and procedures continue to innovate in the market. Increasing social media usage and growing beauty consciousness is expected to increase demand for celebrity smiles, thereby facilitating market growth for dental adhesives in Japan.

Furthermore, this region is expected to see growth in the dental adhesives market due to increased investment in research and development and the need for more affordable, comfortable dental adhesives in the market. As disposable incomes continue to grow, and as government initiatives to promote dental adhesives and FDA-approved adhesives continue to be implemented, the market is likely to grow even further.

A number of dental advancements have contributed to dental advancements in Japan, but age-related tooth loss remains a concern. About 58% of adults worldwide are expected to be edentulous. With a growing number of elderly people becoming edentulous, the need for dentures will increase. The retention, comfort, and efficiency of complete dentures can often be a source of frustration for denture wearers. As a result, dental adhesives in Japan will grow and their usage will increase in the forecast years.

In addition, the increased costs of dental fees caused by Russia’s invasion of Ukraine have led to a rising trend in the cost of dental care, which will negatively impact the growth of dental adhesives in the region.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15784

Key Takeaways

According to the estimates, Japan will continue to dominate the East Asia dental adhesives sector with an estimated market share of 34.3%.
The global market for restoration adhesives is expected to hold 65.7% of the market share by 2022.
Dental adhesives will reach a market value of US$ 2.31 billion by 2022.
The market for dental adhesives will grow in the future with the development of liquid and gel formulations.
Resin-based direct adhesive restorations with remineralizing agents are expected to grow with growing advances.

Competitive Landscape

The companies are adapting their business models to fit the new normal, transforming manual operations into digital ones, and making investments in artificial intelligence and robotic treatments, since these methods are becoming more and more prevalent in the modern world. Furthermore, through the forecast period, top players in the global dental adhesives market are expected to acquire new technology through mergers and acquisitions.

Recent Developments

With Nexus RMGI, Kerr Dental has relaunched a resin-modified antimicrobial luting cement incorporating Smart Response Ion Technology. NexusTM RMGI, the first RMGI with advanced NexusTM Technology, provides sustained ion release to help prevent secondary caries, easy cleanup, outstanding bond strength, and good color stability. Besides offering ease of use, recent studies show that the NexusTM RMGI also helps to prevent secondary caries with sustained ion release.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15784

Key Market Segments Covered in Dental Adhesives Industry Research

By Product:

Denture Adhesives
Restorative Adhesives

By Formulation:

Creams
Powders
Liquid
Others

By Distributional Channel:

Dental Clinics
Hospitals
Dental Academic and Research Institutes
Others

About FMI:

Electronic Stethoscope Market is expected to reach a valuation around US$ 259 Mn in 2022 | FMI

[263 Pages Report] Up from nearly half a million units sold in 2018, the global sales of electronic stethoscopes will observe a robust 7.2% growth in 2022. The electronic stethoscopes market is expected to create an incremental opportunity worth US$ 170.9 Mn between 2022 and 2029.

Key Manufacturers Continue to Strategize on New Product Launches in Electronic Stethoscopes Landscape

Almost 2/5^th of total adoption of electronic stethoscopes is registered at hospitals, the report underscores that there has been significant adoption by medical institutes in the recent past. In the next few years, medical institutes and ambulatory surgical centers are likely to create multiple opportunities for manufacturers of electronic stethoscopes.

More than half of the overall sales is accounted by amplifying electronic stethoscopes, as indicated by FMI’s analysis. While amplifying electronic stethoscopes provide results as accurate as digitizing electronic stethoscopes, the latter are associated with high maintenance owing to the presence of multiple electronic components. Amplifying electronic stethoscopes are thus expected to observe significant growth in revenue over the course of coming years.

Request Sample @– https://www.futuremarketinsights.com/reports/sample/rep-gb-9457

According to the report, the market attractiveness of amplifying stethoscopes is strongly backed by the increasing number of launches of new electronic stethoscopes by a number of small- and medium-sized companies. Electronic stethoscopes are rapidly replacing conventional variants across developed countries, predominantly owing to accelerated regulatory approvals.

eKuore had launched the first wireless stethoscope for medical use.
Eko had launched the first Android–connected digital stethoscope.
In April 2018, Steth IO launched a digital smartphone-enabled stethoscope.

According to the report, approximately 60% of the electronic stethoscopes that are sold are enabled with Bluetooth technology and an integrated chest piece system. The former is however poised to witness a higher rate of adoption over the coming years.

North America Continues to Lead the Global Market for Electronic Stethoscopes

North America holds a considerable revenue share in the electronic stethoscopes market. With advancements in technology and the presence of a large number of healthcare facilities, electronic stethoscopes are being widely used in the region. Their ability to provide amplified sound output as well as reduce external sound makes it easy for medical professionals to detect sounds and provide proper treatment to patients.

FMI’s study has profiled some of the key companies operating in the global electronic stethoscopes market, including Eko Devices, eKuore, GlobalMed, 3M, Welch Allyn, Ambisea Technology Corp., Meditech Equipment Co., Ltd, HD Medical, Thinklabs, ADInstruments, and Cardionics Inc.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9457

Electronic Stethoscope Market by Category Product:

Amplifying Stethoscopes
Digitizing Stethoscopes

End User:

Hospitals
Clinics
Medical Institutes
Ambulatory Surgical Centers
Homecare Settings
Medical Camps
Catheterization Laboratories

Application:

Integrated Chest-Piece System
Wireless Transmission System (Bluetooth)
Integrated Receiver Head-Piece System
Other

About FMI:

Endoscopic Ultrasound Needles Market is expected to reach a valuation of US$ 223.5 Mn by 2027 | FMI

According to the latest study by Future Market Insights (FMI), global endoscopic ultrasound needles market size is projected to increase from a valuation of US$ 180.2 Mn in 2022 to US$ 223.5 Mn by the end of 2027

The endoscopic ultrasound needles market is witnessing the advent of wide range of products including technological advancements in FNA and FNB for solid lesions. Endoscopic ultrasound have gained wide acceptance among surgeons as minimally invasive procedure along with EUS guided needles as the safe and minimally invasive method driving endoscopic ultrasound needles market growth.

Download Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9247

Manufacturers in the endoscopic ultrasound needles market are focusing on new product launches for more precise diagnosis of tissues collected using needles. Gaining a greater share in the endoscopic ultrasound needles market with diverse portfolio is one of the key strategies of leading players.

As per the report, companies in the endoscopic ultrasound needles market are also focusing on collaborating for development and distribution of advanced endoscopic ultrasound needle products.

Key players in endoscopic ultrasound needles market are focusing on new product development in emerging regions including Latin America and Asia Pacific owing to the increasing prevalence of cancer and other chronic diseases.

Endoscopic Ultrasound-Guided Fine Needle Aspiration to Gain Popularity with Rise in Gastrointestinal Diseases

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9247

According to the FMI report, Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) is likely to account for largest share in the endoscopic ultrasound needles market. EUS-FNA gaining popularity for the diagnosis of gastrointestinal diseases and peri-gastrointestinal lesions. The wide application of FNA has also accelerated the growth in the endoscopic ultrasound needles market.

With the growing demand for minimally invasive procedures, doctors and surgeons are using EUS combined with FNA to collect sample fluid and tissue from chest and abdomen for diagnosis. It has also emerged as an alternative to exploratory procedure.

Meanwhile, in recent years studies conducted on Endoscopic Ultrasound-Guided Fine Needle Biopsy (EUS-FNB) have shown some promising results. As per the FMI study on endoscopic ultrasound needles market, FNB is emerging as the novel tool in diagnosis by providing information on tissue architecture.

As per the study, ambulatory surgical centres will use endoscopic ultrasound needles on a large scale owing to the rise in number of these centres and increasing number of endoscopic ultrasound surgeries performed in ambulatory surgical centres.

Being the minimally invasive and non-surgical procedure that can be performed through colon or upper GI tract, ambulatory surgical centers are gaining traction in the endoscopic ultrasound needles market.

Moreover, endoscopic ultrasound is generally considered safe when performed at ambulatory surgical centres with expert healthcare team. Various healthcare organisations are building ambulatory surgical centres within the premises in the healthcare facility offering wide range of services with technological advancements to achieve economies of scale.

Increasing number of ambulatory surgical centers are offering safe, cost-effective services, especially for gastroenterology, thereby, driving the demand in the endoscopic ultrasound needles market.

Contact Sales for Further Assistance in Purchasing this Report https://www.futuremarketinsights.com/checkout/9247

Endoscopic Ultrasound Needles Industry Survey

Endoscopic Ultrasound Needles Market by Product:

Aspiration Needles (EUS-FNA)
Biopsy Needles (EUS-FNB)

Endoscopic Ultrasound Needles Market by Application:

Bronchial EUS Needles
Enteral EUS Needles

Endoscopic Ultrasound Needles Market by End User:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Endoscopic Ultrasound Needles Market by Region:

North America Endoscopic Ultrasound Needles Market
Latin America Endoscopic Ultrasound Needles Market
Europe Endoscopic Ultrasound Needles Market
East Asia Endoscopic Ultrasound Needles Market
South Asia & Pacific Endoscopic Ultrasound Needles Market
Middle East & Africa (MEA) Endoscopic Ultrasound Needles Market

More Trending Reports by Future Market Research :

Laboratory Furnaces Market Size : The global laboratory furnaces market is set to surpass US$ 545.1 Mn in 2032 from a valuation of US$ 327.0 Mn in 2022.

Battery Testing Equipment Market Share : The global battery testing equipment market is projected to have a moderate-paced CAGR of 4% during the forecast period.

Food Tester Market Growth : Global food tester market worth is expected to rise at a rate of 8% per year to US$ 42.81 Billion by 2032

About FMI:

Fabric Freshener Market is Expected to Grow at 6% CAGR Over 2022-2032

The global fabric freshener market size to reach a valuation of US$ 3.4 Bn, exhibiting a CAGR of 6% in the forecast period 2022-2032.

The global textile industry is considered as one of the largest industries in the global market. In 2017, the industry was valued at US$ 3 trillion, which also includes the production, refinement, as well as sale of synthetic and natural fibers that are used in various industries.

The global textile market is segmented into fiber, yarn, fabric, and garments. China accounts for a significant production share in the textile products market. The fabric industry has large-scale application in both, the household and industrial sectors.

With continuous improvements being implemented in fabric products, the target segment/target customers look for ways or any kind of product that could help maintain the quality of the fabric for a longer time. As a result, fabric-related products such as fabric fresheners have been gaining traction in the global market. Fabric fresheners are used on carpets, upholstery, rugs, or any kind of clothing in order to avoid or eliminate odours quickly.

Fabric-oriented products such as rugs, carpets, and curtain kinds of woolen cloths are found in a majority of households as well as in the commercial sector. However, over the course of time, these fabric-oriented products get musty or smelly, which requires maintenance at regular intervals.

Request a Report Sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-8578

For maintaining these fabric products, fabric fresheners have been gaining traction in the global market. Fabric fresheners are being designed to eliminate any odour originating from sticky couches, musty carpets, and unwashed curtains.

With the continuous evolution of fabric freshener products, companies have been strategizing on adding additional features to their existing products. Some of the newly featured fabric fresheners not only eliminate the odours on fabric but also act as a pest control against various insects on these materials.

Fabric Freshener Market: Key Players

Some of the key players operating in the global fabric freshener market are Procter & Gamble, Henkel Corporation, JAY Manufacturing, Reckitt Benckiser, Clean Control Corporation, Deb Group Ltd, Grow Fragrance Inc., and The London Oil Refining Co Ltd., among others.

Fabric Freshener Market: Key Trends

Manufacturers of fabric freshener products have been strategizing on promoting their products and services in order to increase their customer base in the global market. Along with key promotional activities, some of the fabric freshener companies have been executing key acquisitions in order to gain a larger customer base.

Fabric Freshener Market: Key Developments

In 2017, Procter & Gamble Co. initiated a nationwide campaign on its fabric freshener brand, i.e. Febreeze, for the North American and European markets.
In 2016, Henkel Corporation acquired major shares of The Sun Products Corporation, which specializes in the production of various fabric freshener products for the household sector.

Use promo code ->> FMITODAY to get flat 20% discount

Opportunities for Fabric Freshener Market Participants

Over the past couple of years, industrialization has been surging at a significant rate in various parts of the world, especially in the Asia Pacific region. With the rise in the commercial sector, it becomes necessary for owner to maintain their office with proper hygienic and also make them environmentally-friendly.

Due to this, these commercial sectors have been looking ways and even buying several hygienic products to maintain their offices. This important factor paves a critical opportunity for the fabric freshener market to gain traction over the forecast period.

The fabric freshener market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The fabric freshener market report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment.

The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Fabric Freshener Market
Technology
Value Chain of the Fabric Freshener Market
Market Drivers and Restraints

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
CIS & Russia
Japan
Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)

For any Queries, Ask an Analyst@
https://www.futuremarketinsights.com/ask-question/rep-gb-8578

Fabric Freshener: Market Segmentation

On the basis of product type, the global fabric freshener market has been segmented as –

Regular
Perfumed

On the basis of end use, the global fabric freshener market has been segmented as –

Households
Commercial
Offices and Industrial Sector
Hospitality Industry
Public Facilities
Others

On the basis of the distribution channel, the global fabric Freshener market has been segmented as –

Direct
Indirect
Hypermarkets/Supermarkets
Specialty Stores
Independent Stores
Online Store
Others

About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Pharmaceutical E-commerce Market is Expected to Grow at a 14.3% CAGR Between 2022-2032

The global pharmaceutical E-commerce market is estimated to reach US$ 72.1 Bn in 2022. The market size is projected to surpass US$ 273.6 Bn by 2032, at a CAGR of 14.3% over the forecast period 2022 to 2032.

In response to the coronavirus pandemic, consumer buying patterns have shifted, internet penetration has increased, and healthcare infrastructure has been established across emerging economies. Further, looking at the wide acceptance towards the online platform, large hospital chains are offering home delivery of medicine along with medical consultation.

Online care and pharmaceutical retail are now an important component of the overall health care delivery system. The increasing expectation for lower prices, regulatory changes, and discounts and offers available at online retail channels will boost sales in the market over the forecast period.

“Wide availability of OTC drugs and medical devices at online channels, along with increasing penetration of digital devices in emerging economies will drive the growth in the market,” says an FMI analyst.

Request a Sample PDF of The Research Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-15074

Key Takeaways:

The global pharmaceutical E-commerce market is expected to gain traction at an impressive 14.3% CAGR, in comparison to the 15.6% CAGR registered between 2017 to 2021.
Based on product type, sales of OTC drugs are expected to remain high.
The U.S. will continue dominating the North America pharmaceutical e-commerce market over the forecast period due to high adoption of digital services in the healthcare sector.
China will lead the East Asia pharmaceutical e-commerce market amid surging demand for at-home delivery of medial devices.
India will emerge as an attractive market owing to rising government initiatives regarding digital services in the healthcare and pharmaceutical sectors.

Competition Landscape

Mergers and acquisitions, as well as product development and innovation, are among the key strategies used by manufacturers to improve sales. Further, companies are coming up with discount offers to gain new customers.

Key players operating in the global pharmaceutical e-commerce market are Netmeds Marketplace Ltd., EasyMedico, Medlife, Amazon.Inc, Apotek, The Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Express Scripts, CVS Health, Optum, Inc., L Rowland & Co (Retail) Ltd, Zur

Rose Group AG, McKesson Corporation, SHOP-APOTHEKE EUROPE N.V., UK Meds Direct Ltd., Walgreens Boots Alliance, Inc., DocMorris among others.

Ask to Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-15074

Segments:

By Product Type:

Prescription Medicine
Over-The-Counter Product

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East and Africa (MEA)

Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market is expected to rise at a steady CAGR of 4.7% from 2022 to 2028 | FMI

[252 Pages Report] The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028, according to a recent research report of Future Market Insights (FMI). The report has envisaged steady growth prospects for the revenue of global benign prostatic hyperplasia prostate treatment market through 2028.

The World Population Prospects’ data (2017) projected that the number of individuals aged 60 years and above will double by 2050, and triple by 2100. With such a high pace estimated for the growth of population aged 60 years and above, it is more likely that the prevalence of aging related health conditions will also increase at a considerable pace in the years to come. A high prevalence rate of benign prostatic hyperplasia (BPH) in men, the demand for improved and more effective treatment options continues to increase at a high rate.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16464

Alpha-blockers & Drugs for Lower UTIs Remain Pivotal in Benign Prostatic Hyperplasia Prostate Treatment

The drug treatment has been vital in treating benign prostatic hyperplasia conditions and lower UTIs, which has been attributed to widespread availability of drug-based benign prostatic hyperplasia prostate treatment. This factor, in particular, will play an instrumental role in driving the growth of the benign prostatic hyperplasia prostate treatment market during the forecast period. Drugs will remain the first choice of treatment for benign prostatic hyperplasia.

Benign prostatic hyperplasia increases the risk of other disorders as well. The most common disorder caused due to benign prostatic hyperplasia is lower UTI (urinary tract infection) for which, Alpha-blockers constitute the first line of treatment. However, other drugs are also available in the market, which offer relief from the benign prostatic hyperplasia symptoms. Other drugs include alpha reductase inhibitors, phosphodiesterase-5 (PDE-5) inhibitors, muscarinic receptor antagonists, and combination drugs.

Key Players:

Pfizer, Inc.,
Valeant Pharmaceuticals Inc.,
Novartis AG,
Bayer AG,
Sanofi S.A.,
GlaxoSmithKline plc.,
Bristol-Myers Squibb and Company,
Teva Pharmaceutical Industries Ltd,
Mylan N.V.,
Merck & Co.,
Cardinal Health Inc., and
Eli Lilly and Company among others.

Additional Questions Answered

Additional questions addressed in this benign prostatic hyperplasia prostate treatment market report are:

What is the revenue potential of the benign prostatic hyperplasia prostate treatment market across North America and Europe?
Who are the key players and what are their product portfolios in the benign prostatic hyperplasia prostate treatment market?
What are the major challenges impacting the growth of the benign prostatic hyperplasia prostate treatment market?
How is the involvement from key regulatory bodies shaping the growth of the benign prostatic hyperplasia prostate treatment market?

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1664

Demand for Benign Prostatic Hyperplasia Prostate Treatment Higher in Developed Regions, Patient Pool Expanding Steadily in Developing Markets

Owing to significantly growing prevalence of benign prostatic hyperplasia in North American men, benign prostatic hyperplasia prostate treatment market is expected to witness strong growth within the region, followed by Europe.

Extensive availability of benign prostatic hyperplasia prostate treatments, increasing clinical trials, improving R&D scenario, higher healthcare spending, and favorable government initiatives will continue to assist the growth of the benign prostatic hyperplasia prostate treatment market in developed regions.

On the other side, Asia Pacific’s benign prostatic hyperplasia prostate treatment market is foreseen to witness significant growth, owing to steadily expanding patient pool due in the region.

UroLift System to Revolutionize the Competitive Landscape of Benign Prostatic Hyperplasia Prostate Treatment Market

Teleflex Incorporated’s NeoTract recently launched UroLift® System as a highly effective, least invasive option for benign prostatic hyperplasia prostate treatment. The UroLift® System is permanently implanted via a transurethral outpatient procedure and predominantly relieves prostate obstruction, which is one of the primary symptoms of benign prostatic hyperplasia. The company has also declared insurance coverage for UroLift® System. While the coverage is being provided by Humana, it is most likely to improve awareness about increasing availability and broadening access of minimally invasive treatment methods in urological conditions such as benign prostatic hyperplasia. This in turn will encourage adoption of UroLift® System among patients seeking effective benign prostatic hyperplasia prostate treatment.

A majority of patients with enlarged prostate continue to perceive medication and surgery as the only available treatment alternatives. However, an increasing number of physician recommendations is advocating the use of The UroLift® System as it eliminates side effects associated with other conventional options of benign prostatic hyperplasia prostate treatment.

For more insights on the overall performance of global benign prostatic hyperplasia prostate treatment market through 2028, write to press@futuremarketinsights.com

Key Segment

Based on treatment type

alpha-blockers
alpha reductase inhibitors
phosphodiesterase-5 (PDE-5) Inhibitors
muscarinic receptor antagonist
combination drugs

Based on distribution channel

institutional sales
retail sales
online pharmacies

About FMI:

Plant Derived Proteins Market is estimated to reach US$ 105 Mn by the end of 2022 | FMI

[273 Pages Report] Production and commercialization of biopharmaceutical proteins with higher therapeutic efficacy have formed a progressive landscape that continues to push the growth of plant derived proteins market. A new Future Market Insights (FMI) report forecasts that the plant derived proteins market will experience a major upturn towards 2029, reaching a value of around US$ 185 Mn. Production of three main therapeutic protein classes, including antibodies, vaccines, and replacement proteins such as albumin, insulin, growth factors, and cytokines will remain industry’s prime focus area.

Plant derived proteins are recognized as natural and environmentally-sustainable than microbial and mammalian cells. Owing to these benefits, there has been an increasing demand for such proteins from biopharmaceutical companies, as raw materials for therapeutic drug production, creating an absolute opportunity for growth of the plant derived proteins market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11038

Attribute	Details
Plant Derived Proteins Market Estimated Size in 2022	US$ 105 Mn
Plant Derived Proteins Market Projected Size in 2029	US$ 184.3 Mn
Plant Derived Proteins Market Historical CAGR (2014-2021)	7.6%
Plant Derived Proteins Market Value-based CAGR (2022-2029)	8.4%

Key Takeaways of Plant Derived Proteins Market Study

The production of therapeutic proteins for disease treatment will gain traction, contributing more than 70% to global market revenues in 2029.
Owing to low setup cost, transient plant expression systems (carrot or tobacco) remains preferred among protein manufacturers.
Regenerative medicine-therapeutic agents continue to be the leading application area, on the back of their relatively cheap price point.
Biopharmaceutical companies represent the leading consumer industry of plant derived proteins, with over 50% share in market throughout the forecast period.
North America continues to lead, whereas East Asia holds the promise of lucrative opportunities, owing to several healthcare programs.

Acquisition Key Strategy Followed by Leading Market Players

Leading manufacturers in the plant derived proteins market are focusing on regional acquisition strategy to enhance their product portfolio and expand their regional presence. For instance, in 2017, Denka buys pharming pioneer Icon Genetics, which is a leading manufacturers of therapeutic proteins in plants. In 2014, Kentucky BioProcessing, Inc. was acquired by Reynolds American Inc., which is a wholly owned subsidiary of tobacco manufacturing company British American Tobacco plc.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-11038

Interested in more insights on the build-up of plant derived proteins market?

Plant derived proteins market, a new study from future market insights, opines on the production of plant derived proteins from 2014 – 2018 and presents demand projections from 2019 – 2029 on the basis of; plant type (tobacco, carrot, rice, barley and others), protein type (industrial proteins & enzymes, therapeutic proteins cell culture functional proteins and others), application (regenerative medicine-therapeutic agents, regenerative medicine-functional material, cell culture application and others), platform (in-vitro culture system, whole plants and others) and end user (biopharmaceutical companies, academic & research institutes, contract research organization (CROS), contract manufacturing organization (CMOS)) across seven prominent regions.

The global plant derived proteins market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Plant

Tobacco
Rice
Carrot
Barley
Others

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11038

Protein

Industrial Proteins& Enzymes
Therapeutic Proteins
Blood Proteins
Cell Culture Functional Proteins
Others

Platform

In-vitro Cell Culture Systems
Whole Plants
Others

Application

Regenerative Medicine-Therapeutic Agents
Regenerative Medicine-Functional Material
Cell Culture Application
Others

End User

Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organization (CROs)
Contract Manufacturing Organization (CMOs)

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Lung Cancer Surgery Market is expected to reach US$ 1.98 Bn by 2029 | Exclusive Report by FMI

[252 Pages Report] Over 2 million new cases of lung cancer were registered globally by the end of 2021, as reported by the American Cancer Society, Inc. The global lung cancer surgery landscape currently represents a US$ 1 Bn market and will expand at a strong CAGR during the period of projection, 2022 – 2029. A new Future Market Insights (FMI) report states that the use of techniques that are minimally invasive, video assisted, and robot assisted is growing, which is shaping the future of lung cancer surgery market.

Robotic thoracic surgery would remain highly preferred over traditional surgical techniques, as it offers higher magnification, more precision, and eliminate the need for large-incision operations. Development of new surgical robots may cut down the cost of devices and increase shift towards robotic lung cancer surgery. Introduction of new imaging techniques for enhancing visualization, angled lenses for enhanced accessibility, and end staplers will continue to enhance the video-assisted lung cancer surgery procedure.

Intuitive Surgical is the sole player in robotic lung cancer surgery market with its DaVinci system. Medtronic and Johnson & Johnson are developing surgical robots and are challenging the monopoly of Intuitive Surgical in lung cancer surgery market.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-396

Key Takeaways – Lung Cancer Surgery Market Study

Introduction of powered and tissue-specific endoscopic stapling technology provides significant benefits to reduce cost, resource usage, improve clinical outcome compared to manual staplers.
- In September 2022, Johnson & Johnson launched ECHELON CIRCULAR™ Powered Stapler for thoracic, colorectal, and gastric surgery.
- In March 2016, Intuitive Surgical Inc. got U.S. FDA approval for its da Vinci Xi Endowrist Stapler 30 (30 mm) instruments and reloads.
Key market players are focusing on the development of new robot-assisted thoracic surgery system. Partnerships & collaborations with best in class surgical device and visualization technology developers are the strategic focus of manufacturers. For instance,
- Medtronic partnered with Karl Stroz, a best in class endoscopic imaging devices manufacturer. In June 2022, Medtronic announced its upcoming robotic-assisted surgical platform including three-dimensional vision systems from Karl Stroz.
East Asia is expected to be the prominent region in the lung cancer surgery market during the forecast year. This is attributed to high prevalence of lung cancer in China & Japan increasing the demand for lung cancer surgery. According to the International Agency for Research on Cancer, from overall cancer patients in China and Japan, around 18.1% and 16.8% patients respectively were having lung cancer.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-396

Development in robotic thoracic surgery platforms and innovation in tissue-specific endoscopic stapling and vessel sealing techniques to reduce endoleak complications will further broaden the growth prospects of the lung cancer surgery market.

Product Portfolio Expansion to Increase Global Footprint

Manufacturers are adopting product portfolio expansion strategy to increase their footprint in the global lung cancer surgery market. Market players such as Pentax Medical, Olympus, Johnson & Johnson, Intuitive Surgical Inc. are continuously focusing on new product launches and regulatory approvals. For instance,

In July 2016, PENTAX Medical launched new DEFINA high-definition pulmonology endoscopy system for crystal clear imaging during surgical procedures.
In April 2018, Intuitive Surgical Inc. received U.S. FDA clearance for da Vinci Vessel Sealer Extend single-use, the fully wristed bipolar electrosurgical instrument for lung cancer surgery procedures such lobectomy, segmentectomy, and wedge resection.

Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-396

Lung Cancer Surgery Market by Category By Product:

Thoracoscopes
Mediastinoscopes
Bronchoscopes
Robotic-Assisted Thoracic Surgery Systems
Surgical Staplers
Surgical Energy Instruments
- Advanced Energy Instruments
  - Advanced Bipolar Instruments
  - Ultrasonic Instruments
- Basic Energy Instruments
  - Bipolar Instruments
  - Monopolar Instruments

By Application:

Lobectomy
Segmentectomy
Wedge Resection
Pneumonectomy

By End-User:

Hospitals
Ambulatory Surgical Centers

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Car Seat & Accessories Market is Anticipated to Secure A CAGR of 4.5% During The Forecast Period

The car seat and accessories demand is anticipated to be valued at US$ 5 Billion in 2021, and is expected to reach US$ 5.3 Billion by 2022. The market is further forecast to grow at a CAGR of 4.5% to be valued at US$ 8.3 Billion from 2022 to 2032. Growth is attributed to an influential automotive industry well-entrenched in terms of technology and product offering.

The global automobile industry is well established globally and has been steadily evolving in terms of technology and product offerings to cater to the large customer base around the globe. Moreover, it plays a pivotal role in driving the economic growth of any developing or developed country.

As a globally prominent industry, it is critical that the automotive industry stays ahead of the curve in terms of technology, with ongoing developments in automotive components and products. Car seats and accessories are examples of such components that have undergone constant development at regular intervals.

Get a Sample to Understand More Details@
https://www.futuremarketinsights.com/reports/sample/rep-gb-8502

Global Car Seat and Accessories Market: Market Participants

Some of the key players operating in the global car seat and accessories market are Pheonix seating limited, Morrck Ltd., Clek Inc., Britas Römer, RDM Group, Amvian Automotive (Pvt.) Ltd., Diono LLC and Lear Corporation, among others.

Car Seat and Accessories Market: Key Developments

In 2017, Lear Corporation, a key player in the global car seat and accessories market, announced the acquisition of Grupo Antolin’s seating business. Grupo Antolin specializes in the production of various car seat and accessories for North America and Europe markets

In 2018, Britas Römer another marquee player in car seat and accessories launched a new variant of car seat under the brand name of KIDFIX XP SICT and DUALFIX.

Car Seat and Accessories Market: Key Trends

Prominent car seat and accessories manufacturers have been making several key acquisitions in the view of expanding their business in the global market.

Ask to Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-8502

Opportunities for Car Seat and Accessories Market Participants

Over the years, customer perception has been changing with time and new technologies in the market. This factor has also been influencing the global car seat and accessories market. Customers desire to customize their car seat and accessories in accordance with their preference.

Furthermore, families with newborns or toddlers take extra precautions to ensure that their vehicles are equipped with baby care car seats, creating a huge opportunity for competitors in the global car seat and accessory market to gain traction in the baby care or infant care category.

Brief Approach to Research for Car seat and Accessories Market

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions.

By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: regional markets, product type, application and sales channel.

The study is a source of reliable data on

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis

The regional analysis covers

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)